Ajay Kumar Shukla
机构:Dr. Ram Manohar Lohia Avadh University, Atal Bihari Vajpayee Institute of Medical Sciences and Dr. Ram Manohar Lohia Hospital, Pharmacology Research Institute, Institute of Medical Sciences · ORCID:0000-0002-1164-6056
发表论文 89 篇 · 总被引 916 次 · h-index 11
代表论文
- Teplizumab: type 1 diabetes mellitus preventable? (2023 · European Journal of Clinical Pharmacology · 被引 10)
- A Comprehensive Overview of US-FDA-Approved Anticancer Drugs and Biologics in 2023: An Observational Study (2025 · Journal of Pharmacy And Bioallied Sciences · 被引 7)
- Evidences and therapeutic advantages of donanemab in the treatment of early Alzheimer’s disease (2023 · Journal of Basic and Clinical Physiology and Pharmacology · 被引 7)
- Improving the quality of healthcare in resource-constrained settings: is improving undergraduate medical education quality the way out? (2023 · BMJ Open Quality · 被引 6)
- Seladelpar: a comprehensive review of its clinical efficacy and safety in the treatment of primary biliary cholangitis (2025 · Journal of Basic and Clinical Physiology and Pharmacology · 被引 3)
- Predicting unicompartmental arthroplasty success: a three year Indian study (2024 · International Orthopaedics · 被引 2)